Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01110395 · ClinicalTrials.gov registry record · NA
Phosphorous Magnetic Resonance Spectroscopy of Heart
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01110395 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT01110395, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Heart needs constant supply of energy to continue working. Phosphorus magnetic resonance spectroscopy allows us to measure energy produced in the heart. The purpose of this study is to determine if the energy production is reduced in failing heart.
Interventions
- DIAGNOSTIC_TEST MR Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01110395
The ClinicalTrials.gov registry entry for NCT01110395 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR Spectroscopy is the first listed.
NCT01110395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01110395 about?
NCT01110395 is a clinical study titled "Phosphorous Magnetic Resonance Spectroscopy of Heart". Heart needs constant supply of energy to continue working. Phosphorus magnetic resonance spectroscopy allows us to measure energy produced in the heart. The purpose of this study is to determine if the energy production is reduced in failing heart.
What is the current status of trial NCT01110395?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01110395?
The interventions under investigation include: MR Spectroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01110395?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.